BMY R&D Expenses

Bristol Myers Squibb · R&D Expenses

BMY logo

BMY R&D Expenses

Latest reported$2.96B
BMY Quarterly R&D Expenses ($0.00 → $2.96B)
High-resolution chart · PNG

BMY r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bristol Myers Squibb R&D Expenses — Quarterly (USD)
Period endingR&D Expenses (USD)
2,959,000,000
2,649,000,000
2,586,000,000
2,528,000,000
2,580,000,000
2,257,000,000
3,191,000,000
2,374,000,000
2,899,000,000
2,695,000,000
2,478,000,000
2,242,000,000
2,258,000,000
2,321,000,000
2,510,000,000
2,418,000,000
2,321,000,000
2,260,000,000
2,607,000,000
2,980,000,000
2,478,000,000
2,219,000,000
3,750,000,000
2,499,000,000
2,522,000,000
2,372,000,000
2,087,000,000
1,378,000,000
1,325,000,000
1,348,000,000
1,380,000,000
1,280,000,000
2,435,000,000
1,250,000,000
1,921,000,000
1,561,000,000
1,679,000,000
1,303,000,000
1,400,000,000
1,138,000,000
1,266,000,000
1,136,000,000
1,916,000,000
1,132,000,000
1,856,000,000
1,016,000,000
1,189,000,000
983,000,000
1,416,000,000
946,000,000
957,000,000
893,000,000
951,000,000
930,000,000
1,082,000,000
951,000,000
962,000,000
909,000,000
1,008,000,000
973,000,000
923,000,000
935,000,000
1,010,000,000
824,000,000
822,000,000
910,000,000
1,057,000,000
820,000,000
811,000,000
908,000,000
1,143,000,000
834,000,000
826,000,000
782,000,000
870,000,000
802,000,000
755,000,000
791,000,000
821,000,000
756,000,000
740,000,000
750,000,000
775,000,000
669,000,000
649,000,000
653,000,000
677,000,000
615,000,000
625,000,000
583,000,000
705,000,000
565,000,000
524,000,000
475,000,000
654,000,000
535,000,000
527,000,000
502,000,000
760,000,000
485,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.